Catheter Precision Q2 FY26 revenue more than quadruples to $1.02 million; operating loss narrows to $4.09 million
VTAK•Costs and operating loss
Cost of revenues rose to $921,000 from $14,000, driven by $899,000 of service costs tied to private aviation charter operations.
Selling, general and administrative expenses increased 35.75% to $3.91 million on higher professional fees and marketing related to the acquisition.
Operating loss narrowed to $4.09 million.
Liquidity and going-concern warning
Cash and cash equivalents totaled $600,000 at June 30, 2026.
Management flagged substantial doubt about the company's ability to continue as a going concern.
Quarterly revenue rises on acquisition-driven service sales
Catheter Precision posted revenue of $1.02 million for the quarter ended June 30, 2026, rising 380.66% from $212,000 a year earlier.
Product revenue climbed 27.36% to $270,000, while service revenue turned to following the acquisition.
